Calcium antagonists as first-choice therapy for low-renin essential hypertensionBÜHLER, F. R.Kidney international. 1989, Vol 36, Num 2, pp 295-305, issn 0085-2538Article

Proceedings/Links and interactions between α-adrenergic and serotonergic receptors, symposium, Lucerne, CHE, March 18-20, 1987VANHOUTTE, P. M; BÜHLER, F. R; BÜHLER, F. R et al.BÜHLER, F. R; BÜHLER, F. R et al.Journal of cardiovascular pharmacology. 1988, Vol 11, issn 0160-2446, 116 p., suppl. 1Conference Proceedings

Proceedings/Symposium on position of beta blockers in antihypertensive therapy, Monte-Carlo, MCO, March 22-24, 1985BUHLER, F. R.Journal of cardiovascular pharmacology. 1986, Vol 8, pp S1-S87, issn 0160-2446, suppl. 6Conference Proceedings

Antihypertensive treatment according to age, plasma renin and raceBUHLER, F. R.Drugs (Basel). 1988, Vol 35, Num 5, pp 495-503, issn 0012-6667Article

Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopyGASSER, P; BÜHLER, F. R.Journal of hypertension. 1992, Vol 10, Num 1, pp 83-86, issn 0263-6352Article

Adrenoceptors, calcium and excitation-contraction coupling: mechanisms and pharmacological interference: Proceedings/International Society of Hypertension satellite symposium, Lucerne, Switzerland, June 16-17, 1984BÜHLER, F. R; BOLLI, P.Journal of cardiovascular pharmacology. 1985, Vol 7, issn 0160-2446, 209 p., suppl. 6Conference Proceedings

Heart failure and the renin-angiotensin system: proceedings/Symposium on ACE inhibition in heart failure, Frankfurt, DEU, April 26, 1986JUST, H; RUDOLPH, W; BÜHLER, F. R et al.Journal of cardiovascular pharmacology. 1987, Vol 9, pp S1-S77, issn 0160-2446, suppl. 2Conference Proceedings

Inhibition of adenylate cyclase activity during the reversible shape change in human plateletsDIMITROV, D. P; BÜHLER, F. R.Biochemical and biophysical research communications (Print). 1988, Vol 152, Num 2, pp 649-657, issn 0006-291X, 9 p.Article

Proceedings/2nd. Basel workshop of methodology in receptor research, Rheinfelden, May 9-11, 1984BÜRGISSER, E; EBERLE, A. N; BÜHLER, F. R et al.Journal of receptor research. 1984, Vol 4, Num 1-6, issn 0197-5110, XIV-704 pConference Proceedings

Update on calcium antagonists in hypertension: I-II/2nd International nitrenpidine symposium, Lisbon, April 17-19, 1986LARAGH, J. H; BÜHLER, F. R.Journal of cardiovascular pharmacology. 1987, issn 0160-2446, 2Vol, VII- 170 p., 154 pConference Proceedings

Personality characteristics and renin in essential hypertensionPERINI, C; RAUCHFLEISCH, U; BÜHLER, F. R et al.Psychotherapy and psychosomatics. 1985, Vol 43, Num 1, pp 44-48, issn 0033-3190Article

Proceedings/Optimization of β-blockers for cardiovascular care, international bisoprolol symposium, Rabat, MAR, November 20-22, 1985BÜHLER, F. R; HAEUSLER, G.Journal of cardiovascular pharmacology. 1986, Vol 8, pp S1-S174, issn 0160-2446, suppl. 11Conference Proceedings

Inhibition of [³H]Gpp(NH)p release from human platelet membranes by GDPBANTA, L. M; BÜHLER, F. R; BÜRGISSER, E et al.Journal of cyclic nucleotide and protein phosphorylation research. 1985, Vol 10, Num 5, pp 511-523, issn 0746-3898Article

Effects of calcium antagonists on atherogenesisKIOWSKI, W; ERNE, P; BÜHLER, F. R et al.Clinical and experimental hypertension. Part A, Theory and practice. 1989, Vol 11, Num 5-6, pp 1085-1096, issn 0730-0077, AArticle

Calcium antagonists: first-line partner for antihypertensive care/3rd. International nitrendipine symposium, Basel, Switzerland, February 10, 1988FROHLICH, E. D; BUHLER, F. R.Journal of cardiovascular pharmacology. 1988, Vol 12, issn 0160-2446, X-187 p, suppl. 4Conference Proceedings

The influence of CGP 28392, A 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolismRESINK, T. J; ERNE, P; BUHLER, F. R et al.European journal of pharmacology. 1985, Vol 113, Num 3, pp 383-393, issn 0014-2999Article

Enhanced platelet cyclic AMP response to prostaglandin E₁ in essential hypertensionRESINK, T. J; BURGISSER, E; BUHLER, F. R et al.Hypertension (Dallas, Tex. 1979). 1986, Vol 8, Num 8, pp 662-668, issn 0194-911XArticle

Efficacy and tolerance of the new long-acting vasodilator RO 12-4713 in hypertensive patients not managed on beta blockers and diureticsAMANN, F. W; BOLLI, P; BUHLER, F. R et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 1, pp 13-15, issn 0174-4879Article

Antihypertensive treatment with dilevalol, a new β-blocking vasodilator, symposium: European Society of Hypertension meeting, 1987BUHLER, F. R.Journal of cardiovascular pharmacology. 1988, Vol 11, issn 0160-2446, V-45 p, Suppl. 2Conference Proceedings

A vascular protective concept in hypertension and heart failureBÜHLER, F. r; ZANCHETTI, A; ERTEM, G et al.Journal of cardiovascular pharmacology. 1994, Vol 24, issn 0160-2446, SUP3Conference Proceedings

Reversible shape change in platelets is regulated by phosphatidylinositol metabolismDIMITROV, D. P; BUHLER, F. R.Biochemical and biophysical research communications (Print). 1986, Vol 141, Num 2, pp 673-681, issn 0006-291XArticle

Inappropriate correction for radioactive decay in fully iodinayed adrenergic radioligandsDOYLE, V. M; BUHLER, F. R; BURGISSER, E et al.European journal of pharmacology. 1984, Vol 99, Num 4, pp 353-356, issn 0014-2999Article

Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokersKIOWSKI, W; LINDER, L; STOSCHITZKY, K et al.Circulation (New York, N.Y.). 1994, Vol 90, Num 1, pp 27-34, issn 0009-7322Article

Acetylsalicyclic acid, at high concentrations, inhibits vascular smooth muscle cell proliferationBERNHARDT, J; ROGALLA, K; LÜSCHER, T. F et al.Journal of cardiovascular pharmacology. 1993, Vol 21, Num 6, pp 973-976, issn 0160-2446Article

Cardiovascular remodeling and its correction : toward a comprehensive strategyBÜHLER, F. R; LARAGH, J. H; HOLZGREVE, H et al.The American journal of medicine. 1993, Vol 94, Num 4A, pp 4A.1S-4A.3S, issn 0002-9343Conference Paper